ArriVent BioPharma, Inc. (AVBP) vs Innovage Holding Corp. (INNV)
A side-by-side comparison of ArriVent BioPharma, Inc. and Innovage Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVBP
ArriVent BioPharma, Inc.
$15.62HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
INNV
Innovage Holding Corp.
$8.99HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — AVBP vs INNV
growth of $100 · dividends reinvested · last 3yAVBP +42.3% (+12.5%/yr)INNV +52.8% (+15.2%/yr)INNV compounded faster over this window
AVBP INNV
AVBP vs INNV: by the numbers
- •INNV is the larger company ($1.22B vs $728M market cap).
- •Both run net losses; AVBP's is the smaller (0.00% vs -0.26% net margin).
Metrics side by side
Valuation
| Metric | AVBP | INNV |
|---|---|---|
| Forward P/E | N/A | 20.42 |
| P/S ratio | N/A | 1.23 |
| P/B ratio | 1.98 | 5.18 |
| EV / EBITDA | N/A | 14.34 |
| FCF yield | N/A | 4.14% |
Profitability
| Metric | AVBP | INNV |
|---|---|---|
| Gross margin | 0.00% | 21.39% |
| Operating margin | 0.00% | 6.39% |
| Net margin | 0.00% | -0.26% |
| ROE | -44.63% | -1.08% |
| ROIC | -47.96% | 9.48% |
Growth (annualized)
| Metric | AVBP | INNV |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.19% |
| Total return CAGR (5Y) | N/A | 5.55% |
Go deeper
Dig into the metrics
ArriVent BioPharma ROEInnovage ROEArriVent BioPharma operating marginInnovage operating marginArriVent BioPharma revenue growthInnovage revenue growthArriVent BioPharma free cash flowInnovage free cash flow
ArriVent BioPharma & Innovage appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.